172@29@17@107!~!172@29@0@53!~!|news|business|companies|natco-pharma-ties-upgileadhepatitis-c-drugs-1173261.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Mar 02, 2015 04:01 PM IST | Source: Reuters

Natco Pharma ties up with Gilead on hepatitis C drugs

Natco will fix its own price for the generic versions, and will pay a royalty on sales to Gilead, the company said.

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Natco Pharma Limited said on Monday it signed a licensing deal with Gilead Sciences Inc to make and sell generic versions of the US drugmaker's chronic hepatitis C medicines.


Drugs under the deal include sofosbuvir, a combination of ledipasvir and sofosbuvir, and GS-5816, which is in late-stage clinical trials, Natco said in a statement.

Natco will fix its own price for the generic versions, and will pay a royalty on sales to Gilead, the company said.

Close
First Published on Mar 2, 2015 01:35 pm
Sections